Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myocardial apoptosis and ischemic preconditioning.

Zhi-Qing Zhao1, Jakob Vinten-Johansen

  • 1Department of Cardiothoracic Surgery, The Carlyle Fraser Heart Center/Crawford Long Hospital, Emory University School of Medicine, 550 Peachtree St. NE, Atlanta, GA 30308-2225, USA. zzhao@emory.edu

Cardiovascular Research
|August 6, 2002
PubMed
Summary

Ischemic preconditioning (IP) limits myocardial necrosis and apoptosis, key cell death types in heart attack recovery. Understanding IP

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathophysiology of Angiotensin II-Mediated Hypertension, Cardiac Hypertrophy, and Failure: A Perspective from Macrophages.

Cells·2024
Same author

Ferroptosis: A potential target of macrophages in plaque vulnerability.

Open life sciences·2023
Same author

Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update.

Molecules (Basel, Switzerland)·2023
Same author

Nickel Foam Coated by Ni Nanoparticle-Decorated 3D Nanocarbons as a Freestanding Host for High-Performance Lithium-Sulfur Batteries.

ACS applied materials & interfaces·2023
Same author

Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension.

European journal of pharmacology·2022
Same author

Efficacy and safety of long-term transcutaneous electroacupuncture versus sham transcutaneous electroacupuncture for delayed gastric emptying after distal gastrectomy: study protocol for a randomized, patient-assessor blinded, controlled trial.

Trials·2022

Area of Science:

  • Cardiovascular Science
  • Cell Biology
  • Pathophysiology

Background:

  • Myocardial ischemia and reperfusion induce necrosis and apoptosis, contributing to heart muscle cell death and infarction.
  • Ischemic preconditioning (IP) is an endogenous mechanism that protects the heart by limiting cell death, particularly necrosis.
  • While IP's effect on necrosis is well-studied, its precise impact on apoptosis over time after reperfusion requires further investigation.

Purpose of the Study:

  • To elucidate the time course of apoptosis inhibition by IP following prolonged reperfusion.
  • To highlight the role of apoptosis in extending lethal myocyte injury during reperfusion.
  • To summarize the mechanisms by which IP reduces apoptosis.

Main Methods:

  • Review of existing literature on myocardial cell death (necrosis and apoptosis) during ischemia-reperfusion.

Related Experiment Videos

  • Analysis of the temporal effects of ischemic preconditioning (IP) on apoptosis.
  • Exploration of molecular mechanisms underlying IP-mediated apoptosis inhibition.
  • Main Results:

    • Early IP reduces apoptosis by modulating inflammatory responses and altering apoptotic protein expression.
    • The exact time course and effectiveness of delayed IP in attenuating apoptosis remain unclear.
    • IP demonstrates a significant inhibitory effect on both necrosis and apoptosis during reperfusion.

    Conclusions:

    • Apoptosis plays a critical role in the progression of myocyte injury post-reperfusion.
    • Understanding the 'window of opportunity' for IP's anti-apoptotic effects is crucial for developing new therapeutic strategies.
    • Further research into IP's mechanisms for inhibiting apoptosis could lead to improved treatments for ischemia-reperfusion injury.